|
|
|
European Pharmaceutical Contractor
|
The international pharmaceutical industry is one of the most highly R&D-intensive, more so than the electronics, communications and aerospace industries. The pharma industry faces a continuing challenge to employ the right kind of people, as market leadership depends not only on highly specialised skills, but also on experience.
US Dominance
US pharmaceutical companies are the leaders in the global pharmaceutical industry and this is expected to continue in the future (1). The ability to invest substantially in R&D is critical to a company's future growth potential. With the advantage of having the lion's share of the bestselling products, US companies have been in a stronger position to spend more on R&D than their European and Japanese rivals.
In 2001, the US pharmaceutical industry invested more than US$30 billion in discovering and developing new medicines (2). This high level of R&D investment resulted in increased productivity, hence the US pharmaceutical industry has generated more novel drug substances than its European and Japanese counterparts in each five year period since 1965 (1, 3).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Dr Faiz Kermani, Budgets Proposals and Marketing Executive, Linda White, Head of Contract Personnel, and Pietro Bonacossa, Marketing Executive, at Chiltern International
Dr Faiz Kermani currently works in Business Development at Chiltern International where his role covers bids, proposals and marketing. He previously worked in Business Development at CMR International, examining R&D productivity issues for pharmaceutical industry clients.
Faiz has also worked as a Research Analyst for a Danish health care consultancy, Informedica A/S, focusing on global pharmaceutical pricing and parallel importation.
He holds a PhD in Immunopharmacology from St Thomas' Hospital, London and a First Class honours degree in Pharmacology with Toxicology from King's College, London.
Linda White is Head of the Contract Personnel Department at Chiltern International. Following on from a degree in Psychology, she spent several years looking at psychometric testing in clinical trials. Linda joined Chiltern in 1997, initially in Quality Assurance, before being given the opportunity to develop the Contract Personnel Department a year later.
Pietro Bonacossa is a Marketing Executive at Chiltern International in Atlanta, USA. He holds a BA degree in International Trade from Auburn University and an MBA in Marketing from Georgia State University. Prior to joining Chiltern, Pietro spent two years at Turner Broadcasting Systems, working as a Project Co-ordinator for CNN Headline News and as a Public Relations Liaison for CNN.com.
|
|
|
|
|
|
 |
Industry Events |
 |
First-in-Human Workshop
7-8 May 2012, Berlin, Germany
More info >>
|
|
 |
News and Press Releases |
 |
Pantec Biosolutions Showcases P.L.E.A.S.E.® Professional at the IMCAS Annual Congress
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will present its recently launched P.L.E.A.S.E.® Professional laser device at the International Master Course on Aging Skin (IMCAS) from 26th-29th January 2012 in Paris, France.
More info >> |
|
|
